Compass Therapeutics (CMPX) Revenue (2024)
Compass Therapeutics (CMPX) posted Revenue of $850000.0 for Q2 2024.
Powered by 
Analysis
Compass Therapeutics (CMPX) Revenue (2024) Analysis & Trends
Compass Therapeutics has reported Revenue for 1 years, with the latest figure at $850000.0 in Q2 2024.
- Quarterly Revenue changed N/A year-over-year to $850000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2025 was $850000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $850000.0, changed N/A from the prior year.
- Revenue was little changed at $850000.0 in Q2 2024 per CMPX's latest filing.
- Over five years, Revenue peaked at $850000.0 in Q2 2024 and troughed at $850000.0 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Compass Therapeutics | 449.25 Mn | 449.25 Mn | - | - |